These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 3719855)

  • 21. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
    Nasri H; Baradaran A; Naderi AS
    Acta Med Austriaca; 2004 Aug; 31(3):67-72. PubMed ID: 15515479
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disposition kinetics of dibekacin in patients with renal failure and in patients undergoing hemodialysis.
    Arancibia A; Baillarie D; Bravo M; Chávez J
    Int J Clin Pharmacol Ther; 1995 Nov; 33(11):623-7. PubMed ID: 8688988
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of ceftriaxone in subjects with renal insufficiency.
    Kowalsky SF; Echols RM; Parker MA
    Clin Pharm; 1985; 4(2):177-81. PubMed ID: 3987216
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Citrate kinetics in patients receiving long-term hemodialysis therapy.
    Bauer E; Derfler K; Joukhadar C; Druml W
    Am J Kidney Dis; 2005 Nov; 46(5):903-7. PubMed ID: 16253731
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dialyzability and pharmacokinetics of indomethacin in adult patients with end-stage renal disease.
    Skoutakis VA; Acchiardo SR; Carter CA; Wojciechowski NJ; Straughn AB; Meyer MC
    Drug Intell Clin Pharm; 1986 Dec; 20(12):956-60. PubMed ID: 3816544
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comparison of passage, in the vitreous body, of cefotaxime and cefoperazone].
    Carlhant D; Bonissent JF; Guedes Y; Le Garrec J; Rakotoseheno JC; Colin J; Riche C
    Therapie; 1987; 42(3):267-71. PubMed ID: 3660321
    [No Abstract]   [Full Text] [Related]  

  • 27. Serum levels of mecillinam in patients with severely impaired renal function.
    Svarva PL; Wessel-Aas T
    Scand J Infect Dis; 1980; 12(4):303-5. PubMed ID: 6256847
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Concentrations of mecillinam and ampicillin determined in serum and renal tissue: a single-dose pharmacokinetic study in patients undergoing nephrectomy.
    Ostri P; Frimodt-Møller C
    Curr Med Res Opin; 1986; 10(2):117-21. PubMed ID: 3709211
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mecillinam in patients on haemodialysis.
    Bailey K; Cruickshank JG; Bisson PG; Radford BL
    Br J Clin Pharmacol; 1980 Aug; 10(2):177-80. PubMed ID: 6252916
    [No Abstract]   [Full Text] [Related]  

  • 30. Tolerance in patients with terminal renal insufficiency of high doses of cefotaxime.
    Höffler D; Wittgens T; Piper C
    Infection; 1985; 13 Suppl 1():S151-5. PubMed ID: 4055048
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Probable cefotaxime interference in enzymatic ammonia assay--a cautionary note.
    Kirk JM
    Ann Clin Biochem; 1989 Mar; 26 ( Pt 2)():195-6. PubMed ID: 2729867
    [No Abstract]   [Full Text] [Related]  

  • 32. Probable cefotaxime interference in enzymatic ammonia assay.
    Dalton RN
    Ann Clin Biochem; 1989 Sep; 26 ( Pt 5)():461-2. PubMed ID: 2817764
    [No Abstract]   [Full Text] [Related]  

  • 33. Correction to: Pharmacokinetics and Dialyzability of a Single Oral Dose of Amenamevir, an Anti-Herpes Drug, in Hemodialysis Patients.
    Tsuruoka S; Endo T; Seo M; Hashimoto N
    Adv Ther; 2020 Nov; 37(11):4758-4764. PubMed ID: 32930967
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cefotaxime. An update of its pharmacology and therapeutic use.
    Todd PA; Brogden RN
    Drugs; 1990 Oct; 40(4):608-51. PubMed ID: 2083516
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Doses of antibiotic in patients with renal insufficiency.
    Ohkawa M; Kuroda K
    Clin Ther; 1981; 4 Suppl A():124-32. PubMed ID: 6275994
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Single-dose kinetics and dosage of mecillinam in renal failure and haemodialysis.
    Schapira A
    Clin Pharmacokinet; 1984; 9(4):364-70. PubMed ID: 6088153
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of intravenous cefotaxime in patients undergoing chronic hemodialysis.
    Chodos J; Francke EL; Saltzman M; Neu HC
    Ther Drug Monit; 1981; 3(1):71-4. PubMed ID: 6262952
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of catheter-restricted filling with cefotaxime and heparin on the lifespan of temporary hemodialysis catheters: a case controlled study.
    Saxena AK; Panhotra BR
    J Nephrol; 2005; 18(6):755-63. PubMed ID: 16358235
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dialyzability of cefotaxime and mecillinam.
    el-Guinedy M; el Said W; Sabbour MS
    Chemioterapia; 1986 Jun; 5(3):208-12. PubMed ID: 3719855
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.